Home/Filings/4/0000899243-18-025192
4//SEC Filing

Milligan Peter J 4

Accession 0000899243-18-025192

CIK 0001461993other

Filed

Sep 24, 8:00 PM ET

Accepted

Sep 25, 6:05 PM ET

Size

5.8 KB

Accession

0000899243-18-025192

Insider Transaction Report

Form 4
Period: 2018-09-21
Milligan Peter J
Chief Financial Officer
Transactions
  • Award

    Stock Option (right to buy)

    2018-09-21+370,000370,000 total
    Exercise: $4.50Exp: 2028-09-21Common Stock (370,000 underlying)
Footnotes (1)
  • [F1]One-quarter of the options will vest and become exercisable on September 17, 2019 and the remainder will vest and become exercisable in substantially equal monthly installments during the three year period commencing on September 17, 2019, subject to Mr. Milligan's continued service with the Company through the applicable vesting date.

Issuer

MELINTA THERAPEUTICS, INC. /NEW/

CIK 0001461993

Entity typeother

Related Parties

1
  • filerCIK 0001531049

Filing Metadata

Form type
4
Filed
Sep 24, 8:00 PM ET
Accepted
Sep 25, 6:05 PM ET
Size
5.8 KB